瑞维蒂
关于 Revvity
Revvity, Inc. 提供 health science 解决方案, technologies, expertise, and 服务 that deliver complete workflows from discovery to 开发, and diagnosis to cure. It 专注于 translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm 运营 through the following 部分: Life Sciences and Diagnostics. The Life Sciences 部分 delivers innovative 解决方案 to optimize workflows, boost productivity, and accelerate drug discovery and 开发. The Diagnostics 部分 提供 instruments, reagents, assay 平台, and 软件 to 医疗保健 and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was 成立 on April 19, 1937 and is 总部位于 in Waltham, MA.
- 成立时间
- 1937
- 首席执行官
- Dr. Prahlad R. Singh, PhD
- 员工人数
- 11,000
- 总部地址
- Waltham, Massachusetts, United States of America
- 财年结束日
- 12-27
- 官方网站
- revvity.com
公司概况
- 交易所
- US
- 股票代码
- RVTY
- 市值排名
- #1032
- 上市日期
- 1970-01-01
- 市值
- 17.03B
- 流通市值
- 15.64B
- 总股数
- 111.59M
- 流通股数
- 102.49M
行业与主题板块
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
瑞维蒂 讨论区 0 条评论